Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 3/20 | 0.58 |
| ▸ | RAMP3 | O60896 | 7/20 | 0.54 |
| ▸ | CALCR | P30988 | 7/20 | 0.54 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.53 |
| ▸ | NPY2R | P49146 | 6/20 | 0.53 |
| ▸ | NPY4R | P50391 | 6/20 | 0.53 |
| ▸ | NPY5R | Q15761 | 6/20 | 0.53 |
| ▸ | NPY1R | P25929 | 4/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29416007 | 1.00 | APLNR (0.58) | APLNRRAMP3CALCRC5AR1NPY2R | |
| SCHEMBL30495819 | 0.90 | NPY2R (0.59) | APLNRCALCRNPY2RNPY4RNPY5R | |
| SCHEMBL30881892 | 0.89 | C5AR1 (0.70) | C5AR1NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL31307221 | 0.88 | C5AR1 (0.57) | APLNRRAMP3CALCRC5AR1NPY2R | |
| SCHEMBL31307222 | 0.88 | C5AR1 (0.56) | APLNRRAMP3CALCRC5AR1NPY2R | |
| SCHEMBL30712933 | 0.88 | C5AR1 (0.62) | APLNRCALCRC5AR1NPY2RNPY4R | |
| SCHEMBL31670660 | 0.88 | NPY2R (0.66) | APLNRCALCRNPY2RNPY4RNPY5R | |
| SCHEMBL30262145 | 0.88 | MC4R (0.59) | APLNRCALCRC5AR1NPY2RNPY4R | |
| SCHEMBL30512692 | 0.88 | C5AR1 (0.58) | APLNRC5AR1NPY2RNPY4RNPY5R | |
| SCHEMBL29608128 | 0.87 | CXCR4 (0.57) | APLNRC5AR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4275688-A2 | METHOD OF AMELIORATING OR PREVENTING THE WORSENING OR THE PROGRESSION OF SYMPTOMS OF BPH | Nymox Corporation (BS) | 2023-11-15 | — | — | EP | disclosed |